Events

Past Events

Online
|
Oct 19- Oct 20, 2020

Virtual event
This AACR Virtual Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of T-cell and non-T-cell therapies; novel combinations; innate and adaptive checkpoints; and defining novel immunotherapy targets. These world-renowned oncologists and researchers will offer their insights on vaccines, neoantigens, oncolytic viruses, synthetic biology and novel approaches to immune engineering, all in the pursuit of understanding tumor evolution and creating better treatments.

Online
|
Oct 3- Oct 5, 2020

NEW DATE: October 2-3, 2020 Virtual event
The 7th Immunotherapy of Cancer Conference (ITOC7) is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges.
ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munich (CCCM) in Munich.
The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

New York, NY
|
Sep 14- Sep 17, 2020

CANCELLED.
The Cancer Research Institute (CRI), the European Network for Cancer Immunotherapy (ENCI), and the American Association for Cancer Research (AACR) are proud to present the Sixth International Cancer lmmunotherapy Conference.
The 2020 meeting will be held at the New York Hilton Midtown in New York City from September 14-17, 2020. The program will focus on "Translating Science into Survival," and feature talks from more than 50 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy.
This meeting will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.

Online
|
Sep 18- Sep 22, 2020

Virtual event.
The ESMO Congress is the most influential oncology platform in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world. ESMO Congress 2020 will present the very latest advances in oncology and translate science into better cancer patient care.

The ESMO Congress 2020 programme will be developed by a committee composed of more than 300 international experts under the leadership of Scientific Chair Prof John Haanen, NKI Amsterdam, Netherlands, a leading expert in the field of immunotherapy.

Online
|
Aug 24- Aug 25, 2020

Virtual event.
Oxford Global’s Immuno Series features 2 outstanding programmes consisting of key discussion topics in Immuno-Oncology, Autoimmunity, Immunology and Inflammation, enabling attendees to gain actionable insights into the approaches impacting this field from the leading immunotherapy experts.

Join the 5th Annual Advances in Immuno-Oncology Congress on 24-25 August and network with 350+ leaders at the forefront of research into the immune system. Connect with experts from pharma, biotech and academia working on the delivery of innovative immunotherapies.

Online
|
Aug 17- Aug 19, 2020

Virtual event.
Cancer immunotherapy provides unprecedented long-term antitumor activity in some patients, however the majority of patients with advanced cancers only experience short-term remission. To achieve better outcomes for everyone will require a mechanistic understanding of response, and resistance, to these therapies, including immune inhibitory checkpoint blockade and T-cell engineering. These insights will provide rationale for how to best combine these therapeutic approaches for sustained clinical success.

In this virtual meeting we will tackle many of these unanswered questions in the field, including: How do cancers adapt and resist T cell attack? Can we better understand the tumor microenvironment to pave the way for new approaches to immunotherapy? What is the rationale behind immune-oncology (IO) combinations in clinical testing?

Online
|
Aug 10- Aug 14, 2020

Virtual event.
Over the past 8 years, CHI's Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 5-day program and extensive networking opportunities that CHI's IO Summit provides.

Gloucester, MA
|
Jul 20- Jul 24, 2020

NEW DATE to be announced shortly. Hosted by Arthur L. Irving Family Foundation, this symposium/workshop will focus on advancing the careers of young scientists in cancer immunology. Fifteen accomplished faculty mentors will share their research career experience in cancer immunology with ~40 promising young scientists (post-docs, advanced graduate students and starting faculty). Participants will learn how excellent science can be advanced by formulating questions, designing and executing studies to address these questions, hiring, mentoring, collaborating, leadership, raising funds, and publishing. Sessions will include lectures, small discussion/working groups with faculty mentors on specific topics, and review sessions to integrate lessons learned. Participants will also work on updating their research statement to support their next stage of career development. Applicants will be selected by a committee based on the applicant’s research achievements and plans, and recommendations by their mentors. Applications are due by Feb 15, 2020 and participants will be informed of acceptance in March 2020.

Mallorca, Spain
|
Jun 3- Jun 5, 2020

NEW DATE: ICoMI 2020 Congress is a forceful and up-to-date platform where open-minded discussions will promote networking between researchers, clinicians, students and all persons involved in the development of science and medicine. It will be a great opportunity to let new creative and innovative ideas make new collaborations and highlight the latest technology that will help us to reduce the time to find new medication or combinations of treatment especially in the field of chronic diseases.

Paris, France
|
May 14- May 15, 2020

CANCELLED: Since 2017, ITOX 2020 is the first symposium dedicated to immunotherapy toxicities gathering Clinicians, Scientists and Pharmacists to share experiences, expertise and exploration of toxicities to improve knowledge and management of patients treated by cancer immunotherapies. Symposium located at UICP Congress Space, 16 rue Jean Rey - 75015 Paris.

New York, NY
|
May 11- May 12, 2020

In person meeting changed to webinar: This two-day meeting will convene experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response. Key themes under discussion will include tumor evolution, neoantigens, novel therapeutic targets, and mechanisms driving the emergence of resistance to current therapy.

The deadline for abstract submission is Tuesday, March 03, 2020.

Mainz, Germany
|
May 5- May 7, 2020

The CIMT Executive Board has decided to not hold the CIMT Annual Meeting, which was scheduled for May 5-7, 2020, in Mainz, Germany. This decision was made after considering current information, guidance and forecasts issued by the German federal and regional governments concerning the novel coronavirus pandemic.
No alternative date has been scheduled at this point in time, but we will look into opportunities to hold the meeting later this year.
For now, CIMT will refund all registration and exhibitor fees in full.
Refunds will take several weeks. We would like to thank you in advance for your patience.
If you have any questions, please contact CIMT by email at office@cimt.eu.

POSTPONED: In 2020, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.
The CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of neoantigens, combination therapies, microbiota, immune escape, cellular therapy, improving immunity, tumor microenvironment, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.
The short talk sessions will feature more than 40 presentations, selected from all abstract submissions in a double-blind peer review.

San Diego, CA
|
Apr 24- Apr 29, 2020

CANCELLED: The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world.

New York, NY
|
Apr 16- Apr 18, 2020

As a result of the COVID-19 outbreak, the 2020 meeting has been cancelled and will be postponed in Spring 2021. Please check back for additional details for the 2021 meeting dates. You may also email us at admin@henrykunkelsociety.org.

Meeting Chairs: Michel C. Nussenzweig, M.D., Ph.D. and Jeffrey V. Ravetch, M.D., Ph.D, Rockefeller University.

Theme: New Dimensions of Therapeutic Antibodies.

Annual Kunkel Memorial Lecturer: Tadatsugu Taniguchi, PhD, University of Tokyo who will be speaking about advances in the treatment of inflammatory diseases and cancer.

online
|
Mar 19- Mar 19, 2020

The S-TIR™ technology platform: Vaccines based on evolutionary conserved immunological mechanisms for the treatment of both allergy and cancer. Thursday, 19th March, 2020 3:00 PM - 4:00 PM GMT. Presented by Geert Mudde, Founder, Chief Scientific Officer & Managing Director at S-TARget therapeutics. Register here >> http://bit.ly/2PxlkxD

Axamer Lizum, Austria
|
Mar 8- Mar 11, 2020

Lectures and discussion groups covering: mechanisms and methodologies in cancer immunology and immunotherapy, drug development, aspects of clinical translation, and career development.

Winter School features:
Every participant will have the opportunity to give an oral presentation and show a poster of their work.
Program devotes ample time for thorough discussion of participants’ projects with all speakers and faculty.
Speakers and faculty will share their experience in combining science and entrepreneurship in an exciting and fast-moving field.
Time for one-on-one conversations offers participants exclusive networking opportunities to fuel their careers.

Application and call for abstracts:
Applications are open for post-docs and advanced PhD students. Interested scientists must submit a scientific abstract, a CV, and a letter of intent which describes their academic and professional goals and projects.
Please send all required documents to office@cimt.eu by December 15, 2019.

Houston, TX
|
Jan 13- Jan 17, 2020

The SITC Cancer Immunotherapy Winter School is a comprehensive cancer immunotherapy program, taught by leading experts, which provides a deep understanding of the core principles of tumor immunology and cancer immunotherapy as well as developing areas in the field including biomarker technology, validation and clinical integration; clinical trial design, data analysis, and considerations for combination therapies; and effectively writing grants to successfully obtain research funding.

This program was designed to instruct researchers and clinicians to advance scientific discoveries and clinical applications of tumor immunology and cancer immunotherapy. Over the course of five days, attendees first learned the fundamentals in the field and then tailored their educational experience by selecting the track most relevant to their individual needs. The program fostered professional development by facilitating student interaction with faculty and thought leaders in cancer immunotherapy in an intimate setting.

New York, NY
|
Dec 14- Dec 14, 2019

The recent development of immunotherapies to treat cancer has transformed the way that clinicians think about managing their patients with many forms of malignancies. The speed at which basic science and clinical trial information continue to emerge in this area, however, creates practice and/or educational gaps for busy clinicians who strive to maintain state-of-the art care for their patients with cancer. This field is one of the most clinically relevant and exciting areas of novel drug development in oncology.

“But how do I use this information to manage my patients with cancer?”

This is the key question, and the one whose answer ultimately means the most for your patients. The 4th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application will answer that question. Topics of particular interest will be optimal timing of checkpoint inhibitors, identification of patients with cell surface expression of a target antigen who would be good candidates for CAR T-cell treatment, using combination immunotherapies in patients with driver mutations (eg, EGFR/ALK), and the use of combination therapies targeting the IDO pathway in patients with advanced melanoma.

Orlando, FL
|
Dec 7- Dec 10, 2019

Mark your calendar for the world's most comprehensive hematology event of the year, the 61st ASH Annual Meeting and Exposition in sunny Orlando. The meeting will provide an invaluable educational experience and the opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field and a global community of more than 25,000 hematology professionals from every subspecialty.

Boston, MA
|
Nov 17- Nov 22, 2019

Join workshop Course Directors Drs. George D. Demetri, Susan Band Horwitz, and Pasi A. Jänne for an intensive introduction to translational cancer research. This week-long workshop will provide basic scientists with a better understanding of translational research and strategies for adapting their research for maximum clinical impact. Apply by April 30.

Boston, Massachusetts
|
Nov 17- Nov 20, 2019

The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the microbiome; adverse immunological events; imaging and other new technologies; genetics and epigenomics of immuno-oncology; and immunological signaling pathways. These world-renowned oncologists and researchers will offer their insights on novel cell therapies, biomarkers, vaccines and adjuvants, all in the pursuit of understanding tumor evolution and creating better treatments.

National Harbor, MD
|
Nov 6- Nov 10, 2019

The 34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) scheduled to take place Nov. 6-10, 2019, at the Gaylord National Hotel & Convention Center in National Harbor, Md.

Basel, Switzerland
|
Oct 15- Oct 17, 2019

The Festival of Biologics is Europe’s most important gathering of senior health and biologic professionals.

With the combination of four incredible events – #FOB2019 is your opportunity to network with 1500+ attendees, hear from 350+ speakers, explore and be part of this year’s most important Biologics event.

Bangkok, Thailand
|
Oct 11- Oct 13, 2019

This inaugural American Society of Clinical Oncology event, co-hosted by the Thai Society of Clinical Oncology, is the world’s first global summit for oncology innovators. Breakthrough will bring together the very latest in oncology practice, scientific discovery, and technological advances to transform the future of cancer care. Submit your abstract before June 18, 2019.

San Diego, CA
|
Oct 8- Oct 9, 2019

Our conference offers an extensive look across the development and discovery procedures in the Immuno-Oncology field. Day one will focus on the discovery process in Immuno-Oncology such as the key therapeutic strategies like CAR-T Cells therapies, and checkpoint inhibitors. The second stream is dedicated to biomarker development in translational research. Day two will concentrate on clinical aspects of Immuno-Oncology, Stream one focusing on screening techniques and animal models in preclinical development while strategies in trial design and challenges will be widely discussed in stream two.

Key speakers include Executive Directors, Chief Executive Officers and Directors from leading pharma companies within the field such as Merck, Pfizer and Novartis. The conference is co-located with our 4th Annual Biomarkers and Precision Medicine USA Congress, which highlights the latest challenges and developments in clinical biomarkers and personalised medicine. The congresses offer scientific and business discussions with over 300 senior industry experts, ensuring valuable networking and interactive sessions.

View the agenda: https://bit.ly/2vrwiwW. For further information about the congress and get your 20% discount, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk.

Barcelona, Spain
|
Sep 27- Oct 1, 2019

The ESMO Congress is the appointment in Europe for clinicians, researchers, patient advocates, journalists and the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology and translate science into better cancer patient care.

Paris, France
|
Sep 25- Sep 28, 2019

Topics: Cancer prevention and life style factors in oncoimmunology; Combination therapies with immune checkpoint blockers; T cell exhaustion – mechanisms of resistance; Immunotherapies, non-cell-based; Immunotherapies, cell based; New targets and concepts; Tumor antigens; Vaccination strategies; New trends in technology & informatics; TME analysis; Onco- and immunometabolism; Microbiota in oncoimmunology

Boston, MA
|
Sep 10- Sep 13, 2019

A summit focused on accelerating to market the next generation of potent, safe and efficacious CAR-TCR therapies for solid tumor indications, whilst ensuring the accessibility and commercial delivery of currently approved life-changing CAR-TCR therapies to patients around the world.

San Francisco, California
|
Jul 19- Jul 22, 2019

This AACR Special Conference on Immune Cell Therapies for Cancer will focus on the successes and challenges of utilizing a patient’s immune cells to recognize and attack their own cancerous cells. The organizers have designed a meeting that will maximize collaboration between researchers, clinicians, and industry professionals.

Bordeaux, France
|
Jul 11- Jul 12, 2019

This event will be conducted in French.

Les Master Classes de l’immunothérapie est le Grand Rendez-vous Formation en immunothérapie et bioproduction de l’année. Une journée de formations inédites et interactives est organisée. Vous accéderez également à une conférence d’ouverture sur les Biomarqueurs, un cocktail gala, du networking et des ateliers technologiques animés par des industriels.

Les thématiques de formation sont sélectionnées selon les enjeux de la filière : brevet des biomédicament ; Quality by Design ; les Bioassay dans le développement d’un biomédicament ; Contrôle qualité et analyse des mAbs ; Méthode analytique pour évaluer la développabilité de son biomédicament ; Initiation aux CAR T-cells ; Procédés perfusion appliqués à la production d’anticorps ; Purification des mAbs ; Prérequis réglementaires pour entrer en développement clinique.

Tours, France
|
Jun 24- Jun 25, 2019

An ideal conference for researchers, industrials, and clinicians to exchange ideas about therapeutic antibodies. This year's edition will focus on Harnessing the Immune System with mAbs, a major topic chosen by the AIS Scientific Advisory Board constituted by Pierre Fabre, Servier, IRCM, MabDesign, Sanofi, OSE Immunotherapeutics, LFB, CEPR, IGMM, LabEx MabImprove, and Tours University. The AIS2019 will cover the multifaceted mechanisms underlying antibody-mediated immune responses. More than 300 experts are expected this year.

Boston, MA
|
Jun 17- Jun 21, 2019

Most critical scientifically cutting edge and investment-attractive topics will be discussed at the meeting that includes two well established and two new congresses: 15th Annual Biomarker World Congress | 18th Annual World Preclinical Congress | Inaugural Immuno-Oncology Pharma Congress | Inaugural Digital Health Pharma Congress.

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.

New York, NY; São Paulo, Brazil; Paris, France
|
Jun 17- Jun 21, 2019

This summer program gathers exceptional immunology and immunotherapy experts throughout the world to discuss novel perspectives in immunotherapy, review the extraordinary development of novel technology to map immune lesions and discuss the transformative impact of immunomodulatory strategies in the treatment of human cancer, inflammatory diseases and infectious diseases.
This intensive international summer course is designed to serve: graduate students / fellows / academics / clinicians and industry professionals & investors. The lectures will be provided on site either in France (Sorbonne Universités, Paris), in Brazil (University of São Paulo) or USA (Mount Sinai, New York) and transmitted live to all three locations. Lecturers and attendees from the three continents will have the opportunity to discuss live in an open forum.

Wyndham Grand Qingdao, China
|
Jun 11- Jun 13, 2019

This Nature conference brings together leading experts from around the globe to discuss a range of immunotherapeutic approaches and the immunological basis that informs these efforts. Besides covering immune checkpoint inhibitors and cellular therapies, sessions will explore vaccination approaches and oncolytic therapy, the role of innate immune cells and their potential for immunotherapy, the effect of the microbiota on immunotherapy and how to exploit immunometabolism to modulate immune responses in cancer and beyond.

Chicago, IL
|
May 31- Jun 4, 2019

The Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

Mainz, Germany
|
May 21- May 23, 2019

For its 17th edition, the CIMT program committee is preparing plenary sessions from pre-clinical research to clinical development on the topics of neoantigens, cellular therapy, improving immunity, tumor microenvironment, regulatory research and immunoguiding. The plenary sessions will be complemented by a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

London, UK
|
May 20- May 21, 2019

Over 60 presentations will provide the latest case studies across key therapeutic areas such as T-cell therapy, bispecific antibodies, cancer vaccines, checkpoint inhibitors and microbiome-based therapeutics. Further talks look at genomic strategies for cancer immunotherapy, as well as personalising cancer treatments. To enhance the interactivity of the programme, we have also incorporated an increased amount of discussion opportunities through panels, roundtables and workshops on hot topics in the field.

For further information about the programme, registration and discounts please contact a.saez@oxfordglobal.co.uk.

New York, NY
|
May 14- May 15, 2019

This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies. Particular emphasis will be given to the biological mechanisms underlying combination hypotheses, bispecific antibodies and other emerging modalities for delivery of combination therapies, as well as a discussion of the importance of biomarkers and effective clinical trial design.

San Diego, CA
|
May 9- May 13, 2019

The American Association of Immunologists (AAI) is dedicated to advancing the field of immunology and fostering development opportunities for researchers at every career stage. Its members work together to address common interests and push forward the boundaries of knowledge. IMMUNOLOGY 2019 is the leading annual all-immunology event worldwide.

New York, N.Y.
|
May 7- May 8, 2019

Since 1989, Cancer Progress is the only oncology conference that invites a discussion of scientific progress within the context of development, regulatory, clinical, commercial and investment perspectives in two days of interactive dialogue. Pivotal topics, frank discussions, vigorous debate, lively audience participation and generous networking throughout the meeting during breaks, luncheons, reception and dinner combine to make this a highly impactful conference.

Our 30th Annual Meeting on May 7-8, 2019 will provide an unsurpassed learning experience for participants in quality of information, coverage of issues, and value of professional contacts. The quality of the speaking faculty is a major contributor to the popularity and value of this conference.

Houston, TX
|
Apr 25- Apr 27, 2019

This program is ideally suited for North American-based Junior Faculty, Fellows, and Postdoctoral Researchers (MDs, DOs, and PhDs) who are pursuing a career in academic research by conducting basic science, translational, and/or clinical research using immuno-oncology strategies directed at solid tumor or hematologic malignancies.

Amsterdam
|
Apr 23- Apr 25, 2019

At the European NeoAg Summit, we bring together the leading pharma and biotech companies to discuss: Reducing the discordance between various neoantigen prediction methods / Maximising the immune response to neoantigens / Shortening the needle-to-needle time of personalised cancer immunotherapy / Navigating the evolving regulatory landscape to faster approval

Banff, Canada
|
Apr 12- Apr 15, 2019

The Banff Centre is located in the heart of the Canadian Rockies with stunning views and surrounded by natural wildlife. The meeting includes three symposia; workshops; travel awards for graduate students, post-doctoral fellows and new investigators; poster prizes for graduate students; trainee sessions.

Vienna, Austria
|
Apr 11- Apr 13, 2019

The Cancer Drug Development Forum (CDDF) and the Society for Immunotherapy of Cancer (SITC) have the great pleasure to invite you to take part in the 6th Immunotherapy of Cancer Conference (ITOC6) – the leading European conference providing a global platform for translational research in the field of immuno-oncology. The ITOC series of conferences is the premier meeting for education, scientific exchange and networking within cancer immunotherapy. The sixth edition (ITOC6) will take place in Vienna, Austria from April 11-13, 2019.

Boston, MA
|
Apr 8- Apr 12, 2019

PEGS Boston 2019 will host more than 400 lectures, panels, tutorials and round-table discussions, along with 150+ exhibitors, and 300 research posters on display in the exhibit hall. The speaker lineup includes world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions.

Breckenridge, CO
|
Apr 7- Apr 11, 2019

Scientific Organizers: Christian Klein, Mark S. Cragg and Germaine Fuh.

Atlanta, GA
|
Mar 29- Apr 3, 2019

The AACR Annual Meeting program covers the latest discoveries across the spectrum of cancer research—from population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy—and highlights the work of the best minds in research and medicine from institutions all over the world. More information about the AACR Annual Meeting 2019 will be available later online.

Keystone, CO
|
Mar 24- Mar 28, 2019

Scientific Organizers: Nicholas D. Huntington, Eric Vivier, Caroline Robert and Lewis L. Lanier.

Shanghai, China
|
Mar 22- Mar 23, 2019

The program will bring together researchers from the United States, China, and around the world to share the latest developments focusing on translational to clinical applications of immunotherapy with an emphasis on cancers with high incidence in the region. Each session will feature speakers from both China and abroad and offer ample opportunity to foster international scientific exchange.

London, UK
|
Mar 13- Mar 14, 2019

The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADC’s, Bispecific Antibodies and Immune Checkpoint Inhibitors.

Whistler, Canada
|
Mar 10- Mar 14, 2019

Scientific Organizers: Padmanee Sharma, Aviv Regev, Crystal L. Mackall and Kristen Hege.
IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.

San Francisco, CA
|
Feb 28- Mar 2, 2019

Designed for clinicians, scientists, and all other members of the cancer care and research community, this three-day meeting focuses on the clinical application of scientific advances in immuno-oncology. Expert faculty will offer new insights on the application of immunotherapy in lung cancer, genitourinary cancers, melanoma and other skin cancers, breast cancer, and gynecologic cancers. Faculty will also discuss the clinical relevance of immunogenomics, T Cell therapies, cancer vaccines, the microbiome, and promising combination strategies.

Breckenridge, CO
|
Feb 18- Feb 22, 2019

Scientific Organizers: Daniel J. Cua, E. John Wherry and Carla V. Rothlin.

IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.

Mesa, AZ
|
Feb 18- Feb 22, 2019

Taught by leading experts, this five-day program will provide attendees a deep understanding of the core principles of tumor immunology and cancer immunotherapy and examine developing areas in the field.Developed specifically to instruct future scientists and clinicians, the program will first cover the fundamentals of cancer immunotherapy before allowing participants to tailor their experience by selecting the track most relevant to their educational goals.

Seven Springs, PA
|
Feb 13- Feb 15, 2019

Immunotherapy: the force awakens.

With keynote presentations from Ivan M. Borrello, MD and Cynthia L. Sears, MD. For more information or to register, visit www.TRCCC.org

New York City, USA
|
Feb 6- Feb 8, 2019

CIMT is pleased to offer its members a 20% discount to attend the 5th annual Immuno-Oncology 360° meeting, at the Crowne Plaza Times Square, New York City, USA. The 5th annual Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, including the most up-to-date research, data and progress, to help foster collaboration across all IO stakeholders and transform the way cancer is treated. For more information, please go to http://theconferenceforum.org/...Register and use discount code CIMT to receive 20% off.

Maui, HI
|
Jan 30- Feb 2, 2019

The 2019 Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and feature expected advances that you and your patients will likely see in the upcoming year.

London, UK
|
Jan 30- Jan 31, 2019

Now in its 3rd year, the CAR-T Congress Europe in London brings together stakeholders across industry and academia to address the critical challenges head-on and stimulate discussion to identify the unmet needs. Novartis & Kite will share insights on how to accelerate approval in the European market. Get a chance to meet John Maher from King’s College and network with leaders from Novartis, Torque Therapeutics, Cellectis, Celyad, Servier, Gadeta and Bluebirdbio.

Vancouver, Canada
|
Jan 20- Jan 24, 2019

Scientific Organizers: Lélia Delamarre, Robert A. Seder and Nina Bhardwaj. Organized in collaboration with Cancer Research UK.
Abstract submission is now closed. Registered attendees may bring a poster onsite. Please contact our office at +1 800-253-0685; +1 970-262-1230 or email info@keystonesymposia.org if you are interested.

Cairo, Egypt
|
Jan 17- Jan 18, 2019

The 11th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC) is the only conference specialized in breast gynecological cancers in Africa and the Middle-East. The 2019 Scientific Program is designed to give a good platform for the exchange of experience on cancers and to outline the actual status of the problems relating to the Breast and Gynecological cancers, with discussion of the prospects in the context of the most recent international trends and initiatives for the treatment.

Miami, FL
|
Nov 27- Nov 30, 2018

This AACR special conference is designed to integrate multi-disciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. This year’s program will expand our knowledge of the microbiome; metabolic regulation; oncogenic, myeloid, and vascular pathways; and targeted therapies. These world-renowned oncologists and scientist will offer new insights on systems biology, checkpoint, combination therapies, and molecular targets.

San Diego, CA
|
Oct 11- Oct 12, 2018

Due to the success of the UK Advances in Immuno-Oncology event, Oxford Global are expanding this event to the USA. The USA Congress is the first of its kind and will feature over 20 presentations from leading heads of the Pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate.

Topic discussion ranges across a variety of therapeutic strategies, from CAR T cell therapies to microbiome in Immuno-Oncology and from assays and modelling in Immuno-Oncology to NK cell-based therapeutics.

ACIR members wanting to attend this Congress (Academic and Industry attendees only) are eligible for a 20% discount. Contact Danielle Dalby today at d.dalby@oxfordglobal.co.uk and quote IMMUNO20.

New York, NY
|
Sep 30- Oct 3, 2018

The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) are proud to present this program. It will feature talks from more than 60 leaders in the field, covering all areas of inquiry in cancer immunology and immunotherapy. The session topics will include Regulating T Cells and Their Response to Cancer; Tackling the Tumor Microenvironment- beyond T Cells; Genetically Engineered T Cells; Maintenance of Immune Balance: Effects of Targeted and Immune Therapies; Novel Vaccine Platforms and Combinations; Mutational Analysis and Predicting Response to Immunotherapy; Convergence of Technology and Cancer Immunotherapy; Microbiome and Metabolism.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Sao Paulo, Brazil
|
Sep 27- Sep 29, 2018

In cooperation with LAGOS, the conference will present an overview of state-of-the-art translational cancer research. It will explore the latest discoveries in targeted therapies and drug resistance, cancer immunology, drug discovery, and the most common cancers in the region. The session topics will include Immune Checkpoints and The Microbiome and Cancer.

San Diego, CA
|
Sep 17- Sep 18, 2018

Conference deals with the diagnosis, prevention, and treatment of diseases of the organ specific cancers and including the latest techniques. It is an event designed for International medical health professionals and oncologists to facilitate the dissemination and application of research findings related to Cancer. It provides two days of robust discussions on methods and strategies related to management and quality improvement of Cancer therapy, Tumor Biomarkers as well as explore new ideas and concepts on a global scale and the topics include breast cancer, leukaemia, bone cancer, lung cancer, prostate cancer, thyroid cancer, blood cancer, colon cancer and cervical cancer.

Madrid, Spain
|
Sep 13- Sep 15, 2018

The International Conference on Lymphocyte Engineering (ICLE 2018) will provide a dedicated platform to advance research, clinical translation and treatment in immuno-gene therapy. ICLE brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties: oncology, pathogenic diseases, autoimmunity, immunodeficiencies and others.

Boston, MA
|
Aug 27- Aug 31, 2018

Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 5-day, 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs.

Kyoto, Japan
|
Jul 10- Jul 12, 2018

The 6th JCA-AACR special joint conference will bring together basic scientists and clinical researchers from the United States and Japan, and around the world, to share the latest and more exciting developments in lung cancer research. Session topics will include: Novel Immunotherapy Strategies beyond PD-1/PD-L1; Primary and Acquired Mechanisms of Resistance to Immunotherapies; Tumor Microenvironment and Implications for Treatment.

Amsterdam, Netherlands
|
Jun 30- Jul 3, 2018

The theme of the Congress is ‘From Fundamental Insight to Rational Cancer Treatment’, covering the journey of discovery and development ‘from bench to bedside’. The Congress will feature world-class speakers discussing the most innovative current research topics, including a special education track aimed at clinicians. As well as high-profile plenary sessions, the program offers parallel symposia, allowing participants to build their own scientific program according to their interests.

Basel Switzerland
|
Jun 24- Jun 26, 2018

During this Cell Symposium, you will hear about the latest advances in immunometabolism from physician-scientists, basic researchers and industry leaders. We will discuss how local and systemic metabolism are integrated at the cellular level to regulate immune cell function and we will focus on how novel insights into immunometabolism can be harnessed to advance and/or bolster therapeutic interventions in metabolic diseases, inflammation, autoimmunity, and cancer.

Chicago, IL
|
Jun 1- Jun 5, 2018

The Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field.

London, Ontario, Canada
|
Jun 1- Jun 4, 2018

The Canadian Society for Immunology (CSI) is an organization that fosters and supports Immunology research throughout Canada. Founded in 1966, the society provides a focal point for Canadian Immunology by organizing an annual spring meeting that alternates between the west and the east of the country. One of the highlights of the annual meeting is the Cinader Award lecture, named in honor of Hardi Cinader, a founding member of CSI and its first president.

London, UK
|
May 24- May 25, 2018

The 3rd Annual Advances in Immuno-Oncology Congress features over 50 presentations in a revamped conference programme that ensures you will benefit from the latest case studies and high-level scientific debate.

Discussion ranges across a variety of therapeutic strategies, from the discovery of combination therapies to vaccines to checkpoint inhibitors. Further talks look at genomic approaches to cancer immunotherapy and the impact of growing microbiome research on immuno-oncology.

Key Speakers include Chief Executives and Directors from AstraZeneca, Merck, GlaxoSmithKline, Glycostem and many more.

To register using ACIR 20% discount contact a.fernandez@oxfordglobal.co.uk and quote IMMUNO20

Chicago, IL
|
May 16- May 19, 2018

The mission of ASGCT to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.

Mainz, Germany
|
May 15- May 17, 2018

The CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT 2018 invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Plenary sessions will range from pre-clinical research to clinical development on the topics of therapeutic vaccination, cellular therapy, improving immunity, tumor microenvironment, antibodies, regulatory research and immunoguiding. There will also be a poster exhibit and selected poster short talk sessions, as well as industry symposia and industry exhibits.

Boston, MA
|
May 8- May 9, 2018

The Cancer Microbiome Congress will bring together academics, physicians, senior pharma executives and biotechs to learn about the developments and network to improve treatments in future. The speakers presenting at the congress include David Cook from Seres Therapeutics, the first company to develop live microbial therapeutics and Vancheswaran "Deepak" Gopalakrishnan from MD Anderson who published the groundbreaking paper identifying how the gut microbiome influences responses to Anti-PD1-Therapy. See the agenda for the Congress here.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

Chicago, IL
|
Apr 14- Apr 18, 2018

Presentations at the Annual Meeting will cover the latest basic, translational, clinical, and prevention-focused research in the field, including important areas such as early detection, cancer interception, and survivorship in all populations. We will feature new sessions on cancer health disparities that have been inspired by one of the important AACR presidential initiatives. We will also be reprising a popular new feature from Annual Meeting 2017, “Unsolved Mysteries,” featuring provocative questions and their in-depth discussion by speakers and members of the audience.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Boston, MA
|
Mar 20- Mar 22, 2018

CAR-T Congress USA gathers 100+ thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors.

Hear from 25+ industry leaders including Ziopharm, Merck KGaA, GSK, Dana Farber, Celgene and leading research institutions to discuss the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, how to improve patient access, the development of an ‘off-the-shelf’ product and commercializing this new cell therapy.

As a reader of ACIR, you will also benefit from an exclusive 10% discount, simply quote ACIR10 on registering.

*Update: The ACIR team attended several talks at the conference. You can read our coverage here.

Berlin, Germany
|
Mar 19- Mar 21, 2018

The program will focus on the latest challenges and innovations with a special emphasis on combination therapy, immuno-monitoring, and biomarker development.

At this conference, we are in particular addressing preclinical and clinical scientists, clinical investigators, postdoctoral fellows involved in cancer research, regulatory scientists, healthcare professionals, and the pharmaceutical industry.

Close Modal

Small change for you. Big change for us!

This Thanksgiving season, show your support for cancer research by donating your change.

In less than a minute, link your credit card with our partner RoundUp App.

Every purchase you make with that card will be rounded up and the change will be donated to ACIR.

All transactions are securely made through Stripe.